Skip to main content
. 2017 Jan 5;2(2):118–124. doi: 10.1016/j.adro.2016.12.005

Table 1.

Significant lipids obtained from statistical analysis (VIP >1.5; P < .05) in RPs and NRPs at the t0 time point

RT_m/z VIP NRPs
RPs
t test value
Mean SD Mean SD
PCs/SMs 14.79_727.86 1.86 18.03 6.28 23.84 3.91 0.037
16.14_495.7 2.59 9.88 1.53 13.49 2.42 0.001
15.72_480.42 2.27 1.46 0.62 2.24 0.39 0.008
13.44_787.52 2.13 333.95 56.02 183.28 155.44 0.011
13.51_798.84 1.96 2.21 4.71 8.47 6.02 0.025
13.86_842.90 1.71 0.08 0.25 1.88 1.26 0.0001
12.57_830.92 1.70 0.22 0.48 1.01 0.93 0.034
12.58_806.35 1.87 0.25 0.43 1.53 1.78 0.042
12.51_812.58 2.21 0.02 0.07 0.29 0.26 0.008
14.75_757.37 1.83 1.72 2.14 0.00 0.00 0.038
14.91_782.88 1.93 0.11 0.36 1.53 1.78 0.025
14.04_715.12 1.89 0.04 0.14 0.40 0.50 0.047
PEs 9.53_812.96 1.92 22.90 15.93 41.24 20.47 0.048
10.80_478.63 1.78 4.40 8.72 15.31 7.55 0.013
9.83_723.00 1.78 3.15 6.77 12.80 9.44 0.023
11.08_528.61 2.08 1.49 4.71 20.81 25.01 0.028
11.54_750.09 2.46 0.63 2.01 7.78 7.04 0.007
9.67_796.81 2.23 0.93 2.96 17.07 19.23 0.018
9.23_502.71 2.39 7.47 7.17 0.00 0.00 0.010
11.18_532.48 2.05 7.55 9.03 0.00 0.00 0.032
12.35_454.71 1.96 0.73 2.31 6.06 7.27 0.043
9.43_764.26 2.15 6.60 7.41 0.00 0.00 0.024
8.01_555.83 1.92 3.24 4.22 0.00 0.00 0.046
10.10_731.77 2.21 0.00 0.00 7.10 8.62 0.018
7.60_792.30 1.91 3.81 4.98 0.00 0.00 0.047
11.27_939.11 2.16 0.00 0.00 3.70 4.67 0.023
12.36_808.91 1.98 0.00 0.00 3.24 4.61 0.039
PGs 2.55_337.05 2.11 7.66 10.13 34.40 31.77 0.023
6.22_543.15 2.07 1.60 5.07 15.31 16.87 0.026
5.77_763.48 1.86 2.73 8.65 22.98 28.48 0.048
3.16_311.30 2.01 1.15 3.66 9.54 10.76 0.034
12.14_912.39 2.14 9.69 10.56 0.00 0.00 0.020
2.79_367.71 2.04 9.12 10.56 0.00 0.00 0.027
5.83_719.64 2.54 0.00 0.00 13.05 12.30 0.004
3.34_877.71 1.92 1.93 6.11 14.62 16.73 0.040
5.96_913.52 2.33 0.00 0.00 9.74 10.60 0.010
2.73_627.94 1.70 7.51 9.94 0.00 0.00 0.050
2.25_798.51 2.02 0.00 0.00 20.04 28.36 0.039
2.71_501.43 2.34 0.00 0.00 8.52 9.19 0.009
7.16_807.46 2.32 0.00 0.00 6.22 6.78 0.010
PSs 13.60_782.52 2.35 48.23 37.83 104.02 52.04 0.018
15.05_741.50 2.44 11.11 9.65 24.79 11.20 0.013
12.92_879.50 2.45 3.65 7.03 18.01 14.25 0.013
12.84_815.03 2.49 2.95 5.18 18.46 16.20 0.011
13.26_822.49 2.43 4.19 7.38 20.42 16.66 0.014
17.99_600.69 2.13 2.40 3.97 10.04 9.65 0.036
10.48_840.46 2.08 7.75 9.91 0.00 0.00 0.043
13.03_844.46 2.78 12.36 10.11 0.00 0.00 0.003
13.45_786.54 2.50 11.73 10.59 0.71 2.03 0.011
18.56_601.86 2.11 4.04 4.40 0.39 1.12 0.038
13.09_874.69 2.04 7.73 8.80 0.76 2.16 0.045
14.40_838.03 2.04 10.66 13.79 0.00 0.00 0.045
12.85_841.74 2.12 0.81 2.56 8.56 10.51 0.038
17.02_688.96 2.23 0.56 1.79 7.07 8.23 0.026
14.85_596.55 2.26 0.55 1.74 9.20 10.95 0.025
13.81_716.64 2.22 0.78 2.46 6.97 7.66 0.028
16.79_744.77 2.01 2.48 3.29 0.00 0.00 0.050
13.76_748.40 2.47 0.00 0.00 5.36 5.99 0.012
10.50_467.35 2.23 0.00 0.00 4.43 5.76 0.026
14.58_798.73 2.29 0.00 0.00 3.66 4.59 0.022
18.36_614.29 2.08 2.34 3.07 0.00 0.00 0.048
18.81_810.59 2.03 2.71 3.58 0.00 0.00 0.049
14.83_443.05 2.45 0.00 0.00 2.89 3.28 0.013
19.61_732.99 2.43 0.00 0.00 3.20 3.68 0.014
12.03_992.42 2.03 2.41 3.17 0.00 0.00 0.048

Bold type indicates confirmed biomarkers. Lipids are reported as a combination of RT_m/z.

NRP, not responder; PC, phosphatidylcholine; RP, responder; RT_m/z, retention time and mass/charge; SM, sphingomyelin; SD, standard deviation; PE, phatidylethanolamine; PG, phosphatidylglycerol; PS, phosphatidylserine; VIP, variable important for the projection.